Vyaire Medical
Acquisition in 2024
Vyaire Medical is a global medical device company specializing in respiratory diagnostics, ventilation, and anesthesia delivery and patient monitoring. With over fifty years of experience, it is recognized as a leader in these markets and is the largest pure-play company dedicated to breathing support. Vyaire collaborates with healthcare providers and hospitals to enhance patient outcomes and create value in their partnerships. The company offers a range of innovative products and services designed to improve access to clinical data and provide differentiated support. By focusing on the needs of healthcare professionals, Vyaire Medical aims to improve the lives of patients through its advanced technologies and dedicated service, making it a trusted choice in the medical device industry.
Itamar Medical
Acquisition in 2021
Itamar Medical Ltd. is a medical device company based in Caesarea, Israel, specializing in the research, development, marketing, and sale of non-invasive medical devices for the cardiology market. Founded in 1997, the company utilizes its proprietary Peripheral Arterial Tone (PAT) signal technology to create devices that assess various cardiovascular and respiratory conditions. Its flagship products include the WatchPAT device, which facilitates home testing for sleep disorders such as obstructive sleep apnea, and the EndoPAT device, which is designed to diagnose endothelial dysfunction and evaluate the risk of coronary artery disease. Itamar Medical operates across multiple regions, including the United States, Europe, Canada, Japan, and the Asia Pacific. The company also collaborates with SoClean Inc. to enhance the distribution of its home sleep apnea test and digital health services through direct-to-consumer channels.
Respicardia
Acquisition in 2021
Respicardia, Inc. is a medical technology company based in Minnetonka, Minnesota, focused on enhancing respiratory rhythm management and cardiovascular health for heart failure patients. Founded in 2006, the company develops and manufactures innovative implantable stimulation therapy solutions, notably the remede System. This device is designed to restore normal breathing patterns during sleep for individuals suffering from central sleep apnea. Respicardia aims to improve the lives of these patients through safe and effective neurostimulation therapies that stimulate the phrenic nerve, thereby addressing critical needs in respiratory and cardiovascular health.
RoundTrip
Venture Round in 2020
RoundTrip, Inc. operates a digital marketplace that facilitates non-emergency medical transportation by connecting patients with a network of ride providers. Founded in 2014 and based in Philadelphia, Pennsylvania, the company offers a user-friendly software platform that allows healthcare organizations and transportation companies to schedule, dispatch, and monitor patient rides. RoundTrip serves hospitals and health plans in ten states, aiming to improve care coordination and reduce patient no-shows. The platform provides access to various transportation options, including medical cars, wheelchair vans, and stretcher vehicles. RoundTrip has established strategic partnerships with notable healthcare organizations, enhancing its service offerings. The team behind RoundTrip consists of professionals with experience as paramedics and in healthcare management, which informs their approach to addressing the challenges in medical transportation.
Impulse Dynamics
Series D in 2019
Impulse Dynamics N.V. is a medical device company that specializes in developing innovative electrical therapies for chronic heart failure. Founded in 1996 and headquartered in Willemstad, Curacao, the company also maintains offices in New York and Hong Kong, with product development centers located in New Jersey and Israel. Its primary offering, the CCM® therapy, utilizes cardiac contractility modulation technology to deliver non-excitatory electrical impulses to the heart, enhancing its contraction and improving blood flow to the body. This minimally invasive treatment option addresses the needs of heart failure patients who have limited alternatives. Impulse Dynamics conducts clinical trials to assess the safety and efficacy of its therapies and collaborates with universities and hospitals for ongoing research and development.
Mobilize
Acquisition in 2019
Mobilize is a privately held company that focuses on emergency technology, specifically through its Mobilize Rescue Systems app and related rescue kits. The company's offerings are designed to assist individuals in assessing and managing various medical emergencies. Mobilize's technology provides clear instructions and essential supplies for addressing situations such as severe bleeding, cardiac arrest, seizures, choking, chest trauma, hypothermia, and burns. By equipping bystanders with the necessary resources, Mobilize aims to empower them to effectively respond to medical crises and potentially save lives.
TherOx
Acquisition in 2019
TherOx, Inc., established in 1994 and headquartered in Irvine, California, is a privately-held medical device company focused on improving heart attack treatment standards. It specializes in developing dissolved oxygen delivery systems, notably its SuperSaturated Oxygen Therapy (SSO2), which involves creating supersaturated oxygenated blood using the TherOx DownStream system for delivery to coronary arteries. This therapy has shown promise beyond initial heart attack treatment, with potential applications in stroke, oncology, and wound care. As of June 18, 2019, TherOx operates as a subsidiary of ZOLL Medical Corporation. The company holds 20 issued patents, with more pending, reflecting its extensive research and development efforts.
Cardiac Science
Acquisition in 2019
Cardiac Science Corporation specializes in the design, manufacture, and marketing of automated external defibrillators (AEDs) aimed at addressing sudden cardiac arrest (SCA) in various public and private settings. Their product line includes the Powerheart G5 and Powerheart G3 Plus AEDs, which are designed for ease of use in critical situations. The company also offers training devices, such as the Powerheart G5 Trainer and Powerheart G3 Trainer, to prepare users for real-life rescue scenarios. In addition to AEDs, Cardiac Science provides a range of accessories, including wall cabinets, signage, and maintenance kits, alongside services like training and technical support. The company caters to a diverse clientele, including corporations, schools, healthcare facilities, and emergency services. With a global presence, Cardiac Science aims to ensure the availability and simplicity of AEDs to facilitate timely defibrillation and improve survival rates from cardiac incidents. Headquartered in Waukesha, Wisconsin, it operates multiple locations internationally and is a subsidiary of ZOLL Medical Corporation.
Golden Hour
Acquisition in 2019
Golden Hour Data Systems, Inc. specializes in providing integrated solutions for the emergency medical transportation industry, focusing on both air and ground medical transport. The company offers a comprehensive platform that combines dispatch, clinical charting, analytics, and billing services into a single solution, enhancing operational efficiency and maximizing revenue for its clients. Golden Hour Live serves as an Internet-based solution that integrates various functions, including transfer center operations, communications, and flight following, while also ensuring compliance and quality assurance. Additionally, the company provides billing and collections services, along with practice management offerings such as program assessments, training, strategic planning, and data analysis. Recognized as a leader in billing and reimbursement within the air medical transportation sector, Golden Hour supports over 80% of the market through its patented technologies and revenue cycle management services. Founded in 1997 and based in San Diego, California, Golden Hour operates as a subsidiary of ZOLL Medical Corporation.
Payor Logic
Acquisition in 2019
Payor Logic is a company focused on delivering specialized accounts receivable (A/R) software solutions tailored for the healthcare sector. With expertise in areas such as Emergency Medical Services, laboratories, long-term care facilities, physician groups, billing companies, accountable care organizations, and hospitals, Payor Logic provides a comprehensive suite of services. These services include insurance discovery, patient demographic verification, payment likelihood prediction, and prior authorization and eligibility verification. By streamlining these processes, the company helps healthcare providers achieve cleaner patient data, facilitate faster reimbursement, and simplify self-pay management, ultimately enhancing operational efficiency in the healthcare industry.
TherOx
Debt Financing in 2018
TherOx, Inc., established in 1994 and headquartered in Irvine, California, is a privately-held medical device company focused on improving heart attack treatment standards. It specializes in developing dissolved oxygen delivery systems, notably its SuperSaturated Oxygen Therapy (SSO2), which involves creating supersaturated oxygenated blood using the TherOx DownStream system for delivery to coronary arteries. This therapy has shown promise beyond initial heart attack treatment, with potential applications in stroke, oncology, and wound care. As of June 18, 2019, TherOx operates as a subsidiary of ZOLL Medical Corporation. The company holds 20 issued patents, with more pending, reflecting its extensive research and development efforts.
Respicardia
Venture Round in 2017
Respicardia, Inc. is a medical technology company based in Minnetonka, Minnesota, focused on enhancing respiratory rhythm management and cardiovascular health for heart failure patients. Founded in 2006, the company develops and manufactures innovative implantable stimulation therapy solutions, notably the remede System. This device is designed to restore normal breathing patterns during sleep for individuals suffering from central sleep apnea. Respicardia aims to improve the lives of these patients through safe and effective neurostimulation therapies that stimulate the phrenic nerve, thereby addressing critical needs in respiratory and cardiovascular health.
Kyma Medical Technologies
Acquisition in 2015
Kyma Medical Technologies is an early-stage medical device company focused on cardiovascular diagnostics. Founded in March 2008, the company is developing a dual modality non-invasive diagnostic system designed to detect in-stent restenosis. Additionally, Kyma is working on a remote patient monitoring solution specifically for patients with congestive heart failure. This device includes a small patch that adheres to the patient's torso and wirelessly transmits health data to a remote monitoring center via a gateway device, such as a smartphone. Through these innovations, Kyma aims to enhance the management and monitoring of cardiovascular conditions.
Advanced Circulatory System
Acquisition in 2014
Advanced Circulatory Systems specializes in the development and marketing of intrathoracic pressure regulation products designed to enhance circulation and restore life in patients facing cardiac arrest, low blood pressure, and head injuries. The company offers non-invasive technologies that improve blood flow by utilizing the body’s physical mechanisms, without relying on pharmaceuticals or mechanical devices. Its products cater to military, emergency medical services, and hospital markets, and are distributed in over 25 countries globally. By focusing on circulatory enhancement, Advanced Circulatory Systems aims to protect vital organs and improve patient outcomes during critical medical emergencies.
Infusion Dynamics
Acquisition in 2014
Infusion Dynamics is a manufacturer specializing in the design and production of innovative portable medical devices intended for both pre-hospital and hospital settings. The company's flagship product, the Power Infuser, is a miniature infusion pump specifically designed for intravenous fluid resuscitation. Infusion Dynamics primarily markets its devices to the U.S. Military, emphasizing the importance of effective and efficient medical solutions in critical situations. The company is committed to enhancing patient care through its advanced technological offerings in the medical device sector.
CoAxia
Acquisition in 2013
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in the research and development of innovative therapies and treatment solutions for cerebral ischemia. The company focuses on creating devices that control blood flow to the brain, specifically through its neuroflo and flocontrol products. These devices are designed to divert blood flow in patients, thereby helping to reduce the risk of strokes and heart attacks, particularly in individuals experiencing vasospasm and heart blockage. CoAxia aims to improve patient outcomes by providing advanced medical solutions for critical conditions related to cerebral blood flow.
Alsius
Acquisition in 2009
Alsius is a medical device company based in California, specializing in the development and distribution of advanced intravascular temperature management products for critically ill patients. Established in 1991, the company offers a diverse range of products designed for use in intensive care, emergency departments, and surgical settings. Its portfolio includes solutions for bone regeneration, cranial stabilization, epilepsy treatment, neuro-monitoring, and various temperature management systems, all aimed at precisely controlling patient temperature in critical care environments. Alsius is committed to enhancing patient care by providing innovative technologies that facilitate hassle-free temperature management in hospitals.
Radiant Medical
Acquisition in 2007
Radiant Medical is a private medical device company based in Redwood City, California, founded in 1999. The company specializes in endovascular temperature therapy, focusing on innovative solutions for the treatment of heart, brain, and kidney disorders. Radiant Medical's primary product is a comprehensive system that includes a single-use central venous heat exchange balloon catheter, a heat exchange cassette, a microprocessor-driven controller, and an integrated temperature sensor. This system enables healthcare providers to safely and efficiently control patient core body temperature, allowing for rapid cooling, maintenance, and warming as needed during medical procedures.
Pinpoint Technologies
Acquisition in 1999
Pinpoint Technologies is a software development company specializing in computer-aided dispatch and billing solutions for the emergency medical services sector. Founded in 1993 by David Cohen and headquartered in Boulder, Colorado, the company offers a comprehensive product known as RightCAD. This software utilizes a unified database, enabling functionalities such as dispatching, claim verification, automatic pricing, and batch posting of credits. By providing a single integrated platform, Pinpoint Technologies enhances operational efficiency for its customers in the emergency medical services industry.